Mesoblast Limited
MEOBF
$1.90
$0.2515.15%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 68.02% | 68.02% | 16.21% | 16.21% | 2.18% |
| Total Depreciation and Amortization | -1.00% | -1.00% | 107.06% | 107.06% | 94.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -76.06% | -76.06% | -8.80% | -8.80% | -20.69% |
| Change in Net Operating Assets | -125.75% | -125.75% | -4,471.28% | -4,471.28% | -232.53% |
| Cash from Operations | 53.97% | 53.97% | -46.91% | -46.91% | -33.87% |
| Capital Expenditure | 28.40% | 28.40% | -298.11% | -298.11% | -645.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -107.46% | -107.46% | -125.24% | -125.24% | -1.47% |
| Cash from Investing | 17.95% | 17.95% | -196.81% | -196.81% | -5,533.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -818.38% | -818.38% | -1,869.21% | -1,869.21% | 45.63% |
| Issuance of Common Stock | -97.13% | -97.13% | 313.94% | 313.94% | 542.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -67.08% | -67.08% | -272.85% | -272.85% | -27.98% |
| Cash from Financing | -109.37% | -109.37% | 73.55% | 73.55% | 1,652.20% |
| Foreign Exchange rate Adjustments | -39.70% | -39.70% | 178.72% | 178.72% | 227.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -121.91% | -121.91% | -26.65% | -26.65% | 946.39% |